UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 861177
NEW YORK, NY
Position in LGND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$42,503,085
-$26,239,737 QoQ
Shares Held
212,888
-41.4% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 47.96982450866183.ToString("F0")%
Shared 0.ToString("F0")%
None 52.03017549133817.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. LGND ranks #19 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,503,085 | 212,888 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $68,742,822 | 363,584 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $66,711,097 | 376,601 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $44,538,569 | 391,789 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,817,078 | 55,327 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $5,400,465 | 50,401 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,987,382 | 39,838 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,864,918 | 45,869 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,150,520 | 15,739 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,124,077 | 15,739 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $943,079 | 15,739 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,344,736 | 18,651 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,371,964 | 18,651 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,177,081 | 17,621 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $946,562 | 17,621 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $980,749 | 17,621 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,526,297 | 21,750 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,974,636 | 20,493 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,865,215 | 21,461 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,800,483 | 22,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,710,138 | 17,982 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,081,478 | 17,432 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $5,236,650 | 88,065 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,308,564 | 18,754 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $850,409 | 18,746 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||